Labor Market Pulse ArchiveSubscribe to a report

Labor Market Pulse · Life Sciences · September 2026

Life Sciences Labor Market Report: Coeur d'Alene, ID MSA — September 2026

CDA life sci talent pool thins as healthcare absorbs demand.

Coeur d'Alene's 3.7% unemployment rate and a 915-listing RN surge are pulling regional talent toward healthcare, even as the Clinical Research Associate advertised pay median hits $109,557 locally versus $90,956 nationally.

Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.

Key indicators

  • CDA MSA unemployment rate: 3.7% — vs 4.1% national, Aug 2026
  • CRA advertised pay, metro: $109,557 — vs $90,956 national median
  • Idaho biotech employer count: 2 firms — statewide, per listed biotech registry
  • Idaho job posting fill time: 20 days — down from 25 days prior year

Key takeaways

Clinical Research Associate pay premium signals scarcity, not generosity.

Metro advertised median for CRA roles sits at $109,557, roughly 20% above the $90,956 national median — a gap this pronounced in a market with almost no listed biotech employers suggests organizations are bidding up a near-empty local candidate pool rather than reflecting cost-of-living or demand fundamentals. Treat this as a signal to benchmark against regional CRO/CDMO hubs, not Coeur d'Alene norms.

Healthcare's hiring gravity keeps pulling from the same talent pipeline.

Registered nurses posted 915 listings in North Central Idaho alone, competing directly for the same credentialed, licensed workforce that quality, clinical, and regulatory functions draw from. Life sci employers in or near this metro may face longer fill times for any role requiring clinical or scientific credentials as healthcare systems out-recruit on volume.

Idaho's near-absent biotech base limits outsourcing leverage, not just hiring.

Statewide, only two listed biotech firms operate meaningfully, and Alturas Analytics' Assistant Scientist postings at $46K–$63K sit well below national CRO norms — suggesting Idaho-based contract research capacity is underpriced and potentially understaffed. Build-vs-outsource decisions routed through Idaho vendors should weigh retention risk at the vendor level, not just unit cost.

Faster fill times statewide may mask quality tradeoffs for specialist roles.

Idaho postings now fill in 20 days versus 25 a year ago, but that compression is driven by high-volume service and retail hiring, not credential-heavy science and regulatory roles. Faster aggregate fill times should not be read as easier specialist recruitment in this metro.

Median advertised pay by role — Coeur d'Alene, ID MSA

Life Sciences roles, September 2026. Source: WageScape.
Role25th percentileMedian advertised pay75th percentileMetro trendNational median
Research Scientist *$109,700$123,482$149,000Significant increase$131,354
Clinical Research Associate *$60,000$109,557$114,503Significant increase$90,956
Lab Technician *$37,158$42,640$42,640Moderate increase$47,402
Regulatory Affairs Specialist *$68,781$87,850$113,287Moderate increase$104,000
Clinical Data Manager *$103,767$123,998$169,000Significant increase$123,031
Biostatistician *$95,306$128,366$128,486Moderate increase$133,322
Validation Engineer———No data$108,377

* State-level figure shown where metro postings were too few.

WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON

Local market conditions

Coeur d'Alene's labor market tightened modestly in August, with unemployment holding at 3.7% and nonfarm employment dipping 0.3% month-over-month despite a 0.3% year-over-year gain, suggesting a plateau rather than a slowdown. Healthcare and retail continue to dominate hiring demand — registered nurses alone generated 915 postings statewide in the North Central region — pulling general labor supply away from the thin life sciences employer base operating in or near this metro.

What it means

Coeur d'Alene offers no meaningful biotech or pharma manufacturing base, so life sciences organizations hiring here are almost certainly doing so for clinical, regulatory, or commercial functions rather than R&D or production — meaning compensation benchmarking should reference specialty national and regional data, not local industry comps that barely exist. Thin employer density also means any single hire or departure materially moves the local talent equation, raising the stakes on retention for the few specialized roles present. Consider reviewing whether roles advertised against this metro are realistically being filled locally or sourced remotely, since posted pay for positions like Clinical Research Associate running well above the national median may reflect a thin, hard-to-fill regional pool rather than true market value.

Looking ahead

Worth watching: Kootenai County's unemployment rate (4.3% in July, per county-level data) runs meaningfully above the MSA's preliminary 3.7% August reading — a gap worth tracking for signs of labor force composition shifts that could ease or tighten specialist hiring.

Emerging pressure point: North Central Idaho's rising median advertised wage ($27.02) against Southwestern Idaho's declining wage ($28.49, down $1.60 year-over-year) points to regional wage divergence within the state. Watch whether Coeur d'Alene employers start adjusting posted pay to stay competitive with Boise-area science and healthcare employers pulling from an overlapping labor shed.

Potential inflection point: National biopharma layoffs (BioMarin, Bristol Myers) alongside 64% of organizations still actively recruiting suggests displaced specialized talent may enter remote or relocation-eligible candidate pools. Idaho's lower cost of living could make Coeur d'Alene postings newly attractive to senior regulatory or CMC talent shed elsewhere — a recruitment opening worth testing.

Early indicator: Idaho's 8 WARN notices year-to-date, with only 103 workers affected in the last 90 days, indicate stable employer conditions statewide. Sustained calm on this front supports confidence in multi-quarter headcount planning rather than reactive hiring freezes.

Methodology

Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.

Free to read and cite with attribution to WageScape. Terms of use.